{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Prepare Analysis Dataset\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "import igraph as ig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "path = \"../output/cluster-qualifications/cluster-label-tree/cluster_labels_tags_full_raw.json\"\n",
    "with open(path, \"r\") as f:\n",
    "    cluster_labels_tags = json.load(f)\n",
    "\n",
    "path = (\n",
    "    \"../output/cluster-qualifications/cluster-label-tree/cluster_labels_full_raw.json\"\n",
    ")\n",
    "with open(path, \"r\") as f:\n",
    "    cluster_labels = json.load(f)\n",
    "\n",
    "path = \"../output/cluster-qualifications/cluster-label-tree/cluster_tree_full_raw.json\"\n",
    "with open(path, \"r\") as f:\n",
    "    cluster_tree = json.load(f)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### removing the procedural/noise clusters (tag 9), and those with less than 50 papers.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/6m/zjbwrdgj0bg9zyhx3l7134mm0000gn/T/ipykernel_70046/464539718.py:4: RuntimeWarning: Could not add vertex ids, there is already an 'id' vertex attribute. at src/io/graphml.c:488\n",
      "  g = ig.Graph.Read_GraphML(pg)\n"
     ]
    }
   ],
   "source": [
    "pg = \"../data/07-clustered-graphs/alpha0.3_k10_res0.002.graphml\"\n",
    "\n",
    "\n",
    "g = ig.Graph.Read_GraphML(pg)\n",
    "\n",
    "pdf = \"../data/06-clustered-df/alpha0.3_k10_res0.002.pkl\"\n",
    "df = pd.read_pickle(pdf)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Noise Clusters: ['32', '39', '68', '76', '88', '94', '96', '112', '116', '147']\n",
      "32 : Paroxetine\n",
      "39 : Fluoxetine\n",
      "68 : Sertraline for Depression\n",
      "76 : Citalopram for Depression\n",
      "88 : SSRI Use\n",
      "94 : Gatways to Clinical Trials\n",
      "96 : Sertraline\n",
      "112 : Selective serotonin reuptake inhibitors\n",
      "116 : Movement Disorders Associated with Fluvoxamine\n",
      "147 : Gateways to Clinical Trials\n",
      "==================================================\n",
      "Too Few Papers Clusters (<50): ['133', '134', '135', '136', '137', '138', '139', '140', '141', '142', '143', '144', '145', '146', '147', '148', '149']\n",
      "133 : Exercise for Depression\n",
      "134 : SSRIs for Narcolepsy\n",
      "135 : SSRIs for Tourette's Syndrome\n",
      "136 : Adulterants of SSRIs in Weight Loss Supplements\n",
      "137 : Risk of Microscopic Colitis\n",
      "138 : Psilocybin for Depression\n",
      "139 : SSRIs for Psychotic Depression (STOP-PD Study)\n",
      "140 : SSRIs for OCD-like behaviors\n",
      "141 : SSRI Pharmacokinetics After Bariatric Surgery\n",
      "142 : Risk of Priapism\n",
      "143 : SSRIs for Depersonalization Disorder\n",
      "144 : Risk of Reversible Cerebral Vasoconstriction Syndrome (RCVS)\n",
      "145 : Pharmacokinetics and Brain Penetration Studies\n",
      "146 : SSRIs Cellular Distribution\n",
      "147 : Gateways to Clinical Trials\n",
      "148 : Citalopram Effects in Developing Mouse Brain\n",
      "149 : SSRIs for Olfactory reference syndrome (ORS)\n"
     ]
    }
   ],
   "source": [
    "# cluster with less than 50 papers:\n",
    "too_few_papers_50 = [\n",
    "    \"133\",\n",
    "    \"134\",\n",
    "    \"135\",\n",
    "    \"136\",\n",
    "    \"137\",\n",
    "    \"138\",\n",
    "    \"139\",\n",
    "    \"140\",\n",
    "    \"141\",\n",
    "    \"142\",\n",
    "    \"143\",\n",
    "    \"144\",\n",
    "    \"145\",\n",
    "    \"146\",\n",
    "    \"147\",\n",
    "    \"148\",\n",
    "    \"149\",\n",
    "]\n",
    "\n",
    "noise_clusters = [\n",
    "    cluster for cluster, [_, tag] in cluster_labels_tags.items() if tag == 9\n",
    "]\n",
    "\n",
    "print(\"Noise Clusters:\", noise_clusters)\n",
    "for i in noise_clusters:\n",
    "    print(i, \":\", cluster_labels_tags[i][0])\n",
    "print(\"=\" * 50)\n",
    "print(\"Too Few Papers Clusters (<50):\", too_few_papers_50)\n",
    "for i in too_few_papers_50:\n",
    "    print(i, \":\", cluster_labels_tags[i][0])\n",
    "\n",
    "clusters_to_remove = [int(cluster) for cluster in too_few_papers_50 + noise_clusters]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### update dataframe\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(40643, 38)\n",
      "(38473, 38)\n"
     ]
    }
   ],
   "source": [
    "print(df.shape)\n",
    "df_analysis = df[~df[\"cluster_alpha0.3_k10_res0.002\"].isin(clusters_to_remove)]\n",
    "print(df_analysis.shape)\n",
    "\n",
    "df_analysis.to_pickle(\"../data/08-analysis-data/df_analysis.pkl\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### update graph\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Before removal:\n",
      "Number of vertices: 40643\n",
      "Number of edges: 602780\n",
      "\n",
      "After removal:\n",
      "Number of vertices: 38473\n",
      "Number of edges: 559510\n"
     ]
    }
   ],
   "source": [
    "initial_num_vertices = g.vcount()\n",
    "initial_num_edges = g.ecount()\n",
    "\n",
    "nodes_to_remove = [v.index for v in g.vs if v[\"cluster\"] in clusters_to_remove]\n",
    "\n",
    "# Delete the identified nodes from the graph\n",
    "g.delete_vertices(nodes_to_remove)\n",
    "\n",
    "# Get the number of vertices and edges after removal\n",
    "final_num_vertices = g.vcount()\n",
    "final_num_edges = g.ecount()\n",
    "\n",
    "# Save the graph\n",
    "g.write_graphml(\"../data/08-analysis-data/graph_analysis.graphml\")\n",
    "\n",
    "# Display the results\n",
    "print(\"Before removal:\")\n",
    "print(f\"Number of vertices: {initial_num_vertices}\")\n",
    "print(f\"Number of edges: {initial_num_edges}\")\n",
    "\n",
    "print(\"\\nAfter removal:\")\n",
    "print(f\"Number of vertices: {final_num_vertices}\")\n",
    "print(f\"Number of edges: {final_num_edges}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# New Qualifications\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### remove clusters from filtered_cluster_labels_tags\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [],
   "source": [
    "# remove the clusters from the cluster label dict\n",
    "\n",
    "filtered_cluster_labels_tags = {\n",
    "    cluster: label\n",
    "    for cluster, label in cluster_labels_tags.items()\n",
    "    if cluster not in clusters_to_remove\n",
    "}\n",
    "\n",
    "with open(\n",
    "    \"../output/cluster-qualifications/cluster-label-tree/cluster_labels_tags_filtered.json\",\n",
    "    \"w\",\n",
    ") as f:\n",
    "    json.dump(filtered_cluster_labels_tags, f)\n",
    "\n",
    "filtered_cluster_labels = {\n",
    "    cluster: label\n",
    "    for cluster, label in cluster_labels.items()\n",
    "    if cluster not in clusters_to_remove\n",
    "}\n",
    "\n",
    "with open(\n",
    "    \"../output/cluster-qualifications/cluster-label-tree/cluster_labels_filtered.json\",\n",
    "    \"w\",\n",
    ") as f:\n",
    "    json.dump(filtered_cluster_labels, f)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### remove clusters from cluster_tree\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [],
   "source": [
    "def remove_clusters(data, remove_list):\n",
    "    # Traverse the dictionary recursively\n",
    "    for key, value in data.items():\n",
    "        if isinstance(value, list):\n",
    "            # Remove items in `remove_list` from this list\n",
    "            data[key] = [num for num in value if num not in remove_list]\n",
    "        elif isinstance(value, dict):\n",
    "            # Recur for dictionaries\n",
    "            remove_clusters(value, remove_list)\n",
    "\n",
    "\n",
    "def remove_empty_dicts(data):\n",
    "    # Store keys to delete after processing to avoid modifying dict while iterating\n",
    "    keys_to_delete = []\n",
    "\n",
    "    for key, value in data.items():\n",
    "        if isinstance(value, dict):\n",
    "            # Recur on the nested dictionary\n",
    "            remove_empty_dicts(value)\n",
    "            # Mark for deletion if the dictionary is empty after recursion\n",
    "            if not value:\n",
    "                keys_to_delete.append(key)\n",
    "        elif isinstance(value, list) and not value:\n",
    "            # Mark for deletion if it's an empty list\n",
    "            keys_to_delete.append(key)\n",
    "\n",
    "    # Delete all keys marked as empty\n",
    "    for key in keys_to_delete:\n",
    "        del data[key]\n",
    "\n",
    "\n",
    "filtered_cluster_tree = cluster_tree.copy()\n",
    "remove_clusters(filtered_cluster_tree, [int(c) for c in clusters_to_remove])\n",
    "remove_empty_dicts(filtered_cluster_tree)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### put single clusters under the \"Other\" category\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [],
   "source": [
    "# put single clusters under the \"Other\" category\n",
    "\n",
    "filtered_cluster_tree = {\n",
    "    \"Pharmacology\": {\n",
    "        \"Pharmacodynamics\": {\n",
    "            \"Mechanism of action\": [\n",
    "                0,\n",
    "                6,\n",
    "                10,\n",
    "                11,\n",
    "                26,\n",
    "                28,\n",
    "                36,\n",
    "                55,\n",
    "                60,\n",
    "                64,\n",
    "                73,\n",
    "                79,\n",
    "                86,\n",
    "                98,\n",
    "                106,\n",
    "                107,\n",
    "                115,\n",
    "                119,\n",
    "                120,\n",
    "                124,\n",
    "                131,\n",
    "            ],\n",
    "            \"Animal Models of Disorders\": [7, 13, 127],\n",
    "            \"Other\": [69, 92],\n",
    "        },\n",
    "        \"Pharmacokinetics\": [5, 56],\n",
    "        \"Pharmacogenetics\": [18, 80],\n",
    "        \"Analytical Methods\": [3, 129],\n",
    "        \"Other\": [2, 57, 66, 91],\n",
    "    },\n",
    "    \"Indications\": {\n",
    "        \"Disorders\": {\n",
    "            \"Depressive Disorders\": [\n",
    "                7,\n",
    "                8,\n",
    "                9,\n",
    "                13,\n",
    "                17,\n",
    "                18,\n",
    "                19,\n",
    "                22,\n",
    "                24,\n",
    "                30,\n",
    "                34,\n",
    "                42,\n",
    "                47,\n",
    "                49,\n",
    "                59,\n",
    "                61,\n",
    "                74,\n",
    "                77,\n",
    "                83,\n",
    "                84,\n",
    "                85,\n",
    "                90,\n",
    "                92,\n",
    "                95,\n",
    "                93,\n",
    "                109,\n",
    "                102,\n",
    "                103,\n",
    "                105,\n",
    "                105,\n",
    "                106,\n",
    "                110,\n",
    "                114,\n",
    "                117,\n",
    "                118,\n",
    "                119,\n",
    "                122,\n",
    "                124,\n",
    "                127,\n",
    "                131,\n",
    "            ],\n",
    "            \"Anxiety\": [26, 31, 37, 63, 72],\n",
    "            \"Weight and Eating Disorders\": [29, 50],\n",
    "            \"Substance Abuse/Addictions\": [51, 60, 104, 125],\n",
    "            \"Other\": [\n",
    "                4,\n",
    "                14,\n",
    "                23,\n",
    "                25,\n",
    "                35,\n",
    "                40,\n",
    "                41,\n",
    "                45,\n",
    "                48,\n",
    "                52,\n",
    "                53,\n",
    "                54,\n",
    "                58,\n",
    "                62,\n",
    "                69,\n",
    "                70,\n",
    "                89,\n",
    "                99,\n",
    "                100,\n",
    "                101,\n",
    "                111,\n",
    "                121,\n",
    "                123,\n",
    "                130,\n",
    "                126,\n",
    "            ],\n",
    "        }\n",
    "    },\n",
    "    \"Safety\": {\n",
    "        \"Special Populations\": {\n",
    "            \"Pediatrics\": [9, 72],\n",
    "            \"Geriatrics\": [23, 38, 49, 61, 65, 67, 74],\n",
    "            \"Other\": [19, 34, 47, 59, 84, 85, 93, 105, 114, 118, 122],\n",
    "        },\n",
    "        \"Perinatal Exposure\": [2, 12, 102],\n",
    "        \"Suicide\": [7, 27],\n",
    "        \"Sexual Dysfunction\": [15, 91],\n",
    "        \"Toxicity\": [16, 66, 71, 82],\n",
    "        \"Other\": [20, 43, 44, 46, 63, 75, 78, 86, 87, 92, 99, 132],\n",
    "    },\n",
    "    \"Other\": {\n",
    "        \"Ecotoxicology\": [1, 81],\n",
    "        \"Alternative Treatments\": [33, 103],\n",
    "        \"Other\": [21, 30, 53, 97, 108, 128],\n",
    "    },\n",
    "}\n",
    "\n",
    "\n",
    "path = f\"../output/cluster-qualifications/cluster-label-tree/cluster_tree_filtered.json\"\n",
    "\n",
    "with open(path, \"w\") as f:\n",
    "    json.dump(cluster_tree, f)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# create legend for ThreeJS\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Pharmacology': {'Pharmacodynamics': {'Mechanism of action': [{0: 'Serotonin Receptor Modulation in SSRI Treatment'},\n",
       "    {6: 'Impact of SSRIs on Neurogenesis'},\n",
       "    {10: 'SSRIs Effect on Neural Processing of Emotional Cues'},\n",
       "    {11: 'Paroxetine Binding'},\n",
       "    {26: 'SSRIs Effect on Fear'},\n",
       "    {28: 'Structural Basis of Serotonin Transporter Inhibition by SSRIs'},\n",
       "    {36: 'SSRIs and Inflammation'},\n",
       "    {55: 'SSRIs Effects on Neuroendocrine System'},\n",
       "    {60: 'SSRIs for Substance Abuse (Cocaine)'},\n",
       "    {64: 'SSRIs Effects on Ion Channels'},\n",
       "    {73: 'SSRIs Effects on Antimicrobials and Gut Microbiome'},\n",
       "    {79: 'Astrocyte Receptors as a Target for SSRIs'},\n",
       "    {86: 'Repeated SSRIs Exposures Effects on Dopamine Receptors'},\n",
       "    {98: 'SSRIs in Model Organisms ( C. Elegans and Drosophilia)'},\n",
       "    {106: 'Predicting SSRI Response in Depression via miRNA and BDNF'},\n",
       "    {107: 'SSRIs Effect on Reinforcement Learning in Rodents'},\n",
       "    {115: 'Neurochemical and Electrophysiological Correlates of SSRIs'},\n",
       "    {119: 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients'},\n",
       "    {120: 'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases'},\n",
       "    {124: 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression'},\n",
       "    {131: 'Tryptophan Depletion in Depression'}],\n",
       "   'Animal Models of Disorders': [{7: 'The Chronic Unpredictable Mild Stress Model of Depression'},\n",
       "    {13: 'SSRIs in Forced Swimming Test'},\n",
       "    {127: 'Olfactory Bulbectomized (OB) Rat Model of Depression'}],\n",
       "   'Other': [{69: 'SSRIs Effect on Pulmonary Hypertension'},\n",
       "    {92: 'SRRIs and Ocular Safety'}]},\n",
       "  'Pharmacokinetics': [{5: 'SSRIs and the Cytochrome P450 System'},\n",
       "   {56: '(Sertraline) Drug Delivery'}],\n",
       "  'Pharmacogenetics': [{18: 'Serotonin Transporter Gene and Antidepressant Response'},\n",
       "   {80: 'Genotype Mediated Response to SSRIs'}],\n",
       "  'Analytical Methods': [{3: 'Quantification of SSRIs in Biological Samples'},\n",
       "   {129: 'Novel Compounds Synthesis and Antidepressant Potential'}],\n",
       "  'Other': [{2: 'Risks of Prenatal Exposure'},\n",
       "   {57: 'SSRI Synthesis'},\n",
       "   {66: 'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity'},\n",
       "   {91: 'SSRIs Effect on Male Fertility'}]},\n",
       " 'Indications': {'Disorders': {'Depressive Disorders': [{7: 'The Chronic Unpredictable Mild Stress Model of Depression'},\n",
       "    {8: 'Fluvoxamine for Depression'},\n",
       "    {9: 'Pediatric Depression'},\n",
       "    {13: 'SSRIs in Forced Swimming Test'},\n",
       "    {17: 'Sequenced Depression Treatment'},\n",
       "    {18: 'Serotonin Transporter Gene and Antidepressant Response'},\n",
       "    {19: 'Post-Stroke SSRI Use'},\n",
       "    {22: 'SSRIs for Bipolar Depression'},\n",
       "    {24: 'Escitalopram for Depression'},\n",
       "    {30: 'Pharmacoeconomics of SSRIs for Depression'},\n",
       "    {34: ' Depression in Patients with Cardiovascular Disease'},\n",
       "    {42: 'Pharmacological Treatment Strategies of Depression'},\n",
       "    {47: 'SSRIs for Depression in Diabetes Patients'},\n",
       "    {49: 'SSRIs for Depression with Cognitive Impairment'},\n",
       "    {59: 'SSRIs for Depression in in Epileptic Patients'},\n",
       "    {61: 'SSRIs for Depression in Parkinsons Patients'},\n",
       "    {74: 'Geriatric Depression'},\n",
       "    {77: 'Agomelatin for Depression'},\n",
       "    {83: 'SSRIs and Augmentation for Treatment Resistant Depression'},\n",
       "    {84: 'Depression Treatment in Hepatitis Patients'},\n",
       "    {85: 'SSRIs for Depression after Traumatic Brain Injury'},\n",
       "    {90: 'Sex differences in SSRI Response'},\n",
       "    {92: 'SRRIs and Ocular Safety'},\n",
       "    {95: 'Transcranial Direct Current Stimulation (tDCS) for Depression'},\n",
       "    {93: 'SSRIs for Depression in Cancer'},\n",
       "    {109: 'SSRIs for Dysthymia'},\n",
       "    {102: 'SSRIs for Postpartum Depression'},\n",
       "    {103: \"St. John's Wort for Depression\"},\n",
       "    {105: 'SSRIs for Depression in Kidney Disease Patients'},\n",
       "    {105: 'SSRIs for Depression in Kidney Disease Patients'},\n",
       "    {106: 'Predicting SSRI Response in Depression via miRNA and BDNF'},\n",
       "    {110: 'Vilazodone for Depression'},\n",
       "    {114: 'SSRIs for the Mangement of Multiple Sclerosis'},\n",
       "    {117: 'Folate for Depression'},\n",
       "    {118: 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients'},\n",
       "    {119: 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients'},\n",
       "    {122: 'SSRIs for Depression in HIV-positive Patients'},\n",
       "    {124: 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression'},\n",
       "    {127: 'Olfactory Bulbectomized (OB) Rat Model of Depression'},\n",
       "    {131: 'Tryptophan Depletion in Depression'}],\n",
       "   'Anxiety': [{26: 'SSRIs Effect on Fear'},\n",
       "    {31: 'SSRIs for Panic Disorder'},\n",
       "    {37: 'SSRIs for Generalized Anxiety Disorder (GAD)'},\n",
       "    {63: 'SSRIs for Social Anxiety Disorder'},\n",
       "    {72: 'SSRIs for Pediatric Anxiety'}],\n",
       "   'Weight and Eating Disorders': [{29: 'SSRIs for Weight Management'},\n",
       "    {50: 'SSRIs for Eating Disorders'}],\n",
       "   'Substance Abuse/Addictions': [{51: 'SSRIs for Alcohol Dependence'},\n",
       "    {60: 'SSRIs for Substance Abuse (Cocaine)'},\n",
       "    {104: 'SSRIs for Behavioral Addictions'},\n",
       "    {125: 'SSRIs for Smoking Cessation'}],\n",
       "   'Other': [{4: 'SSRIs for Obsessive-Compulsive Disorder (OCD)'},\n",
       "    {14: 'SSRIs for PTSD'},\n",
       "    {23: 'SSRIs in Dementias'},\n",
       "    {25: 'SSRIs for Pain'},\n",
       "    {35: 'SSRIs for (Psycho)dermatological Diseases'},\n",
       "    {40: 'SSRIs Effect on Sleep'},\n",
       "    {41: 'Fluvoxamine for Covid 19'},\n",
       "    {45: 'Premature Ejaculation'},\n",
       "    {48: 'SSRIs for Premenstrual Dysphoric Disorder (PMDD)'},\n",
       "    {52: 'SSRIs for Irritable Bowel Syndrome'},\n",
       "    {53: 'Menopausal Vasomotor Symptoms (Hot flashes)'},\n",
       "    {54: 'SSRIs for Borderline Personality Disorder'},\n",
       "    {58: 'SSRIs for Autism Spectrum Disorders'},\n",
       "    {62: 'SSRIs (Fluvoxamine) for Schizophrenia'},\n",
       "    {69: 'SSRIs Effect on Pulmonary Hypertension'},\n",
       "    {70: 'SSRIs for Body Dysmorphic Disorder (BDD)'},\n",
       "    {89: 'SSRIs for Fibromyalgia'},\n",
       "    {99: 'Risk for Orofacial Pain Disorders'},\n",
       "    {100: 'SSRIs for Enuresis'},\n",
       "    {101: 'SSRIs for Migraine'},\n",
       "    {111: 'SSRIs for Trichotillomania'},\n",
       "    {121: 'SSRIs for Congenital Myasthenic Syndrome (SCCMS)'},\n",
       "    {123: 'SSRIs in the Treatment of Huntington Disease'},\n",
       "    {130: 'SSRIs for Tinnitus '},\n",
       "    {126: 'SSRIs for Syncope'}]}},\n",
       " 'Safety': {'Special Populations': {'Pediatrics': [{9: 'Pediatric Depression'},\n",
       "    {72: 'SSRIs for Pediatric Anxiety'}],\n",
       "   'Geriatrics': [{23: 'SSRIs in Dementias'},\n",
       "    {38: 'Fracture Risk'},\n",
       "    {49: 'SSRIs for Depression with Cognitive Impairment'},\n",
       "    {61: 'SSRIs for Depression in Parkinsons Patients'},\n",
       "    {65: 'Harmful Drug Interactions'},\n",
       "    {67: 'Hyponatremia Risk'},\n",
       "    {74: 'Geriatric Depression'}],\n",
       "   'Other': [{19: 'Post-Stroke SSRI Use'},\n",
       "    {34: ' Depression in Patients with Cardiovascular Disease'},\n",
       "    {47: 'SSRIs for Depression in Diabetes Patients'},\n",
       "    {59: 'SSRIs for Depression in in Epileptic Patients'},\n",
       "    {84: 'Depression Treatment in Hepatitis Patients'},\n",
       "    {85: 'SSRIs for Depression after Traumatic Brain Injury'},\n",
       "    {93: 'SSRIs for Depression in Cancer'},\n",
       "    {105: 'SSRIs for Depression in Kidney Disease Patients'},\n",
       "    {114: 'SSRIs for the Mangement of Multiple Sclerosis'},\n",
       "    {118: 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients'},\n",
       "    {122: 'SSRIs for Depression in HIV-positive Patients'}]},\n",
       "  'Perinatal Exposure': [{2: 'Risks of Prenatal Exposure'},\n",
       "   {12: 'Risk of Perinatal Exposure (Rodents)'},\n",
       "   {102: 'SSRIs for Postpartum Depression'}],\n",
       "  'Suicide': [{7: 'The Chronic Unpredictable Mild Stress Model of Depression'},\n",
       "   {27: 'Suicice Risk'}],\n",
       "  'Sexual Dysfunction': [{15: 'Sexual Dysfunction'},\n",
       "   {91: 'SSRIs Effect on Male Fertility'}],\n",
       "  'Toxicity': [{16: 'Serotonin Syndrome'},\n",
       "   {66: 'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity'},\n",
       "   {71: 'Forensic Drug Concentration'},\n",
       "   {82: 'Hepatotoxic Risk'}],\n",
       "  'Other': [{20: 'Bleeding Risk'},\n",
       "   {43: 'QTC Prolongation'},\n",
       "   {44: 'Oncopreventive and Oncolytic Properties of SSRIs'},\n",
       "   {46: 'Extrapyramidal Reactions Risk'},\n",
       "   {63: 'SSRIs for Social Anxiety Disorder'},\n",
       "   {75: 'SSRI Safety Reviews'},\n",
       "   {78: 'Withdrawal Symptoms'},\n",
       "   {86: 'Repeated SSRIs Exposures Effects on Dopamine Receptors'},\n",
       "   {87: 'Hyperprolactinemia-related Symptoms'},\n",
       "   {92: 'SRRIs and Ocular Safety'},\n",
       "   {99: 'Risk for Orofacial Pain Disorders'},\n",
       "   {132: 'Risk of Hallucinations'}]},\n",
       " 'Other': {'Ecotoxicology': [{1: 'Aquatic Ecotoxicology'},\n",
       "   {81: 'Environmental Degradation of Antidepressants'}],\n",
       "  'Alternative Treatments': [{33: 'Antidepressant-like Effects of Herbal Extracts in Animal Models'},\n",
       "   {103: \"St. John's Wort for Depression\"}],\n",
       "  'Other': [{21: 'SSRI Utilization Patterns'},\n",
       "   {30: 'Pharmacoeconomics of SSRIs for Depression'},\n",
       "   {53: 'Menopausal Vasomotor Symptoms (Hot flashes)'},\n",
       "   {97: 'Canine Behavioral Disorders'},\n",
       "   {108: 'Generic SSRIs'},\n",
       "   {128: 'Critical Psychiatry'}]}}"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def transform_dict_to_legend(cluster_hierarchy_dict, cluster_label_dict):\n",
    "    \"\"\"\n",
    "    Transforms the cluster hierarchy dictionary by adding cluster labels to create a legend.\n",
    "    \"\"\"\n",
    "    # Ensure keys in cluster_label_dict are integers\n",
    "    cluster_label_dict = {int(k): v for k, v in cluster_label_dict.items()}\n",
    "\n",
    "    def transform(item):\n",
    "        if isinstance(item, dict):\n",
    "            return {k: transform(v) for k, v in item.items()}\n",
    "        elif isinstance(item, list):\n",
    "            return [transform(i) for i in item]\n",
    "        elif isinstance(item, int) and item in cluster_label_dict:\n",
    "            return {item: cluster_label_dict[item]}\n",
    "        else:\n",
    "            return item\n",
    "\n",
    "    return transform(cluster_hierarchy_dict)\n",
    "\n",
    "\n",
    "legend = transform_dict_to_legend(filtered_cluster_tree, filtered_cluster_labels)\n",
    "legend"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# D3 JS Structue\n",
    "\n",
    "### Build Full Tree Incl Labels\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Structure saved to ../output/cluster-qualifications/cluster-label-tree/D3JS_cluster_hierarchy_structure.json\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'overview': {'name': 'Topic Overview',\n",
       "  'children': [{'name': 'Pharmacology',\n",
       "    'children': [{'name': 'Pharmacodynamics',\n",
       "      'children': [{'name': 'Mechanism of action'},\n",
       "       {'name': 'Animal Models of Disorders'},\n",
       "       {'name': 'Other'}]},\n",
       "     {'name': 'Pharmacokinetics'},\n",
       "     {'name': 'Pharmacogenetics'},\n",
       "     {'name': 'Analytical Methods'},\n",
       "     {'name': 'Other'}]},\n",
       "   {'name': 'Indications',\n",
       "    'children': [{'name': 'Disorders',\n",
       "      'children': [{'name': 'Depressive Disorders'},\n",
       "       {'name': 'Anxiety'},\n",
       "       {'name': 'Weight and Eating Disorders'},\n",
       "       {'name': 'Substance Abuse/Addictions'},\n",
       "       {'name': 'Other'}]}]},\n",
       "   {'name': 'Safety',\n",
       "    'children': [{'name': 'Special Populations',\n",
       "      'children': [{'name': 'Pediatrics'},\n",
       "       {'name': 'Geriatrics'},\n",
       "       {'name': 'Other'}]},\n",
       "     {'name': 'Perinatal Exposure'},\n",
       "     {'name': 'Suicide'},\n",
       "     {'name': 'Sexual Dysfunction'},\n",
       "     {'name': 'Toxicity'},\n",
       "     {'name': 'Other'}]},\n",
       "   {'name': 'Other',\n",
       "    'children': [{'name': 'Ecotoxicology'},\n",
       "     {'name': 'Alternative Treatments'},\n",
       "     {'name': 'Other'}]}]},\n",
       " 'pharmacology': {'name': 'Pharmacology',\n",
       "  'children': [{'name': 'Pharmacodynamics',\n",
       "    'children': [{'name': 'Mechanism of action',\n",
       "      'children': [{'name': 'Serotonin Receptor Modulation in SSRI Treatment'},\n",
       "       {'name': 'Impact of SSRIs on Neurogenesis'},\n",
       "       {'name': 'SSRIs Effect on Neural Processing of Emotional Cues'},\n",
       "       {'name': 'Paroxetine Binding'},\n",
       "       {'name': 'SSRIs Effect on Fear'},\n",
       "       {'name': 'Structural Basis of Serotonin Transporter Inhibition by SSRIs'},\n",
       "       {'name': 'SSRIs and Inflammation'},\n",
       "       {'name': 'SSRIs Effects on Neuroendocrine System'},\n",
       "       {'name': 'SSRIs for Substance Abuse (Cocaine)'},\n",
       "       {'name': 'SSRIs Effects on Ion Channels'},\n",
       "       {'name': 'SSRIs Effects on Antimicrobials and Gut Microbiome'},\n",
       "       {'name': 'Astrocyte Receptors as a Target for SSRIs'},\n",
       "       {'name': 'Repeated SSRIs Exposures Effects on Dopamine Receptors'},\n",
       "       {'name': 'SSRIs in Model Organisms ( C. Elegans and Drosophilia)'},\n",
       "       {'name': 'Predicting SSRI Response in Depression via miRNA and BDNF'},\n",
       "       {'name': 'SSRIs Effect on Reinforcement Learning in Rodents'},\n",
       "       {'name': 'Neurochemical and Electrophysiological Correlates of SSRIs'},\n",
       "       {'name': 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients'},\n",
       "       {'name': 'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases'},\n",
       "       {'name': 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression'},\n",
       "       {'name': 'Tryptophan Depletion in Depression'}]},\n",
       "     {'name': 'Animal Models of Disorders',\n",
       "      'children': [{'name': 'The Chronic Unpredictable Mild Stress Model of Depression'},\n",
       "       {'name': 'SSRIs in Forced Swimming Test'},\n",
       "       {'name': 'Olfactory Bulbectomized (OB) Rat Model of Depression'}]},\n",
       "     {'name': 'Other',\n",
       "      'children': [{'name': 'SSRIs Effect on Pulmonary Hypertension'},\n",
       "       {'name': 'SRRIs and Ocular Safety'}]}]},\n",
       "   {'name': 'Pharmacokinetics',\n",
       "    'children': [{'name': 'SSRIs and the Cytochrome P450 System'},\n",
       "     {'name': '(Sertraline) Drug Delivery'}]},\n",
       "   {'name': 'Pharmacogenetics',\n",
       "    'children': [{'name': 'Serotonin Transporter Gene and Antidepressant Response'},\n",
       "     {'name': 'Genotype Mediated Response to SSRIs'}]},\n",
       "   {'name': 'Analytical Methods',\n",
       "    'children': [{'name': 'Quantification of SSRIs in Biological Samples'},\n",
       "     {'name': 'Novel Compounds Synthesis and Antidepressant Potential'}]},\n",
       "   {'name': 'Other',\n",
       "    'children': [{'name': 'Risks of Prenatal Exposure'},\n",
       "     {'name': 'SSRI Synthesis'},\n",
       "     {'name': 'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity'},\n",
       "     {'name': 'SSRIs Effect on Male Fertility'}]}]},\n",
       " 'indications': {'name': 'Indications',\n",
       "  'children': [{'name': 'Disorders',\n",
       "    'children': [{'name': 'Depressive Disorders',\n",
       "      'children': [{'name': 'The Chronic Unpredictable Mild Stress Model of Depression'},\n",
       "       {'name': 'Fluvoxamine for Depression'},\n",
       "       {'name': 'Pediatric Depression'},\n",
       "       {'name': 'SSRIs in Forced Swimming Test'},\n",
       "       {'name': 'Sequenced Depression Treatment'},\n",
       "       {'name': 'Serotonin Transporter Gene and Antidepressant Response'},\n",
       "       {'name': 'Post-Stroke SSRI Use'},\n",
       "       {'name': 'SSRIs for Bipolar Depression'},\n",
       "       {'name': 'Escitalopram for Depression'},\n",
       "       {'name': 'Pharmacoeconomics of SSRIs for Depression'},\n",
       "       {'name': ' Depression in Patients with Cardiovascular Disease'},\n",
       "       {'name': 'Pharmacological Treatment Strategies of Depression'},\n",
       "       {'name': 'SSRIs for Depression in Diabetes Patients'},\n",
       "       {'name': 'SSRIs for Depression with Cognitive Impairment'},\n",
       "       {'name': 'SSRIs for Depression in in Epileptic Patients'},\n",
       "       {'name': 'SSRIs for Depression in Parkinsons Patients'},\n",
       "       {'name': 'Geriatric Depression'},\n",
       "       {'name': 'Agomelatin for Depression'},\n",
       "       {'name': 'SSRIs and Augmentation for Treatment Resistant Depression'},\n",
       "       {'name': 'Depression Treatment in Hepatitis Patients'},\n",
       "       {'name': 'SSRIs for Depression after Traumatic Brain Injury'},\n",
       "       {'name': 'Sex differences in SSRI Response'},\n",
       "       {'name': 'SRRIs and Ocular Safety'},\n",
       "       {'name': 'Transcranial Direct Current Stimulation (tDCS) for Depression'},\n",
       "       {'name': 'SSRIs for Depression in Cancer'},\n",
       "       {'name': 'SSRIs for Dysthymia'},\n",
       "       {'name': 'SSRIs for Postpartum Depression'},\n",
       "       {'name': \"St. John's Wort for Depression\"},\n",
       "       {'name': 'SSRIs for Depression in Kidney Disease Patients'},\n",
       "       {'name': 'SSRIs for Depression in Kidney Disease Patients'},\n",
       "       {'name': 'Predicting SSRI Response in Depression via miRNA and BDNF'},\n",
       "       {'name': 'Vilazodone for Depression'},\n",
       "       {'name': 'SSRIs for the Mangement of Multiple Sclerosis'},\n",
       "       {'name': 'Folate for Depression'},\n",
       "       {'name': 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients'},\n",
       "       {'name': 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients'},\n",
       "       {'name': 'SSRIs for Depression in HIV-positive Patients'},\n",
       "       {'name': 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression'},\n",
       "       {'name': 'Olfactory Bulbectomized (OB) Rat Model of Depression'},\n",
       "       {'name': 'Tryptophan Depletion in Depression'}]},\n",
       "     {'name': 'Anxiety',\n",
       "      'children': [{'name': 'SSRIs Effect on Fear'},\n",
       "       {'name': 'SSRIs for Panic Disorder'},\n",
       "       {'name': 'SSRIs for Generalized Anxiety Disorder (GAD)'},\n",
       "       {'name': 'SSRIs for Social Anxiety Disorder'},\n",
       "       {'name': 'SSRIs for Pediatric Anxiety'}]},\n",
       "     {'name': 'Weight and Eating Disorders',\n",
       "      'children': [{'name': 'SSRIs for Weight Management'},\n",
       "       {'name': 'SSRIs for Eating Disorders'}]},\n",
       "     {'name': 'Substance Abuse/Addictions',\n",
       "      'children': [{'name': 'SSRIs for Alcohol Dependence'},\n",
       "       {'name': 'SSRIs for Substance Abuse (Cocaine)'},\n",
       "       {'name': 'SSRIs for Behavioral Addictions'},\n",
       "       {'name': 'SSRIs for Smoking Cessation'}]},\n",
       "     {'name': 'Other',\n",
       "      'children': [{'name': 'SSRIs for Obsessive-Compulsive Disorder (OCD)'},\n",
       "       {'name': 'SSRIs for PTSD'},\n",
       "       {'name': 'SSRIs in Dementias'},\n",
       "       {'name': 'SSRIs for Pain'},\n",
       "       {'name': 'SSRIs for (Psycho)dermatological Diseases'},\n",
       "       {'name': 'SSRIs Effect on Sleep'},\n",
       "       {'name': 'Fluvoxamine for Covid 19'},\n",
       "       {'name': 'Premature Ejaculation'},\n",
       "       {'name': 'SSRIs for Premenstrual Dysphoric Disorder (PMDD)'},\n",
       "       {'name': 'SSRIs for Irritable Bowel Syndrome'},\n",
       "       {'name': 'Menopausal Vasomotor Symptoms (Hot flashes)'},\n",
       "       {'name': 'SSRIs for Borderline Personality Disorder'},\n",
       "       {'name': 'SSRIs for Autism Spectrum Disorders'},\n",
       "       {'name': 'SSRIs (Fluvoxamine) for Schizophrenia'},\n",
       "       {'name': 'SSRIs Effect on Pulmonary Hypertension'},\n",
       "       {'name': 'SSRIs for Body Dysmorphic Disorder (BDD)'},\n",
       "       {'name': 'SSRIs for Fibromyalgia'},\n",
       "       {'name': 'Risk for Orofacial Pain Disorders'},\n",
       "       {'name': 'SSRIs for Enuresis'},\n",
       "       {'name': 'SSRIs for Migraine'},\n",
       "       {'name': 'SSRIs for Trichotillomania'},\n",
       "       {'name': 'SSRIs for Congenital Myasthenic Syndrome (SCCMS)'},\n",
       "       {'name': 'SSRIs in the Treatment of Huntington Disease'},\n",
       "       {'name': 'SSRIs for Tinnitus '},\n",
       "       {'name': 'SSRIs for Syncope'}]}]}]},\n",
       " 'safety': {'name': 'Safety',\n",
       "  'children': [{'name': 'Special Populations',\n",
       "    'children': [{'name': 'Pediatrics',\n",
       "      'children': [{'name': 'Pediatric Depression'},\n",
       "       {'name': 'SSRIs for Pediatric Anxiety'}]},\n",
       "     {'name': 'Geriatrics',\n",
       "      'children': [{'name': 'SSRIs in Dementias'},\n",
       "       {'name': 'Fracture Risk'},\n",
       "       {'name': 'SSRIs for Depression with Cognitive Impairment'},\n",
       "       {'name': 'SSRIs for Depression in Parkinsons Patients'},\n",
       "       {'name': 'Harmful Drug Interactions'},\n",
       "       {'name': 'Hyponatremia Risk'},\n",
       "       {'name': 'Geriatric Depression'}]},\n",
       "     {'name': 'Other',\n",
       "      'children': [{'name': 'Post-Stroke SSRI Use'},\n",
       "       {'name': ' Depression in Patients with Cardiovascular Disease'},\n",
       "       {'name': 'SSRIs for Depression in Diabetes Patients'},\n",
       "       {'name': 'SSRIs for Depression in in Epileptic Patients'},\n",
       "       {'name': 'Depression Treatment in Hepatitis Patients'},\n",
       "       {'name': 'SSRIs for Depression after Traumatic Brain Injury'},\n",
       "       {'name': 'SSRIs for Depression in Cancer'},\n",
       "       {'name': 'SSRIs for Depression in Kidney Disease Patients'},\n",
       "       {'name': 'SSRIs for the Mangement of Multiple Sclerosis'},\n",
       "       {'name': 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients'},\n",
       "       {'name': 'SSRIs for Depression in HIV-positive Patients'}]}]},\n",
       "   {'name': 'Perinatal Exposure',\n",
       "    'children': [{'name': 'Risks of Prenatal Exposure'},\n",
       "     {'name': 'Risk of Perinatal Exposure (Rodents)'},\n",
       "     {'name': 'SSRIs for Postpartum Depression'}]},\n",
       "   {'name': 'Suicide',\n",
       "    'children': [{'name': 'The Chronic Unpredictable Mild Stress Model of Depression'},\n",
       "     {'name': 'Suicice Risk'}]},\n",
       "   {'name': 'Sexual Dysfunction',\n",
       "    'children': [{'name': 'Sexual Dysfunction'},\n",
       "     {'name': 'SSRIs Effect on Male Fertility'}]},\n",
       "   {'name': 'Toxicity',\n",
       "    'children': [{'name': 'Serotonin Syndrome'},\n",
       "     {'name': 'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity'},\n",
       "     {'name': 'Forensic Drug Concentration'},\n",
       "     {'name': 'Hepatotoxic Risk'}]},\n",
       "   {'name': 'Other',\n",
       "    'children': [{'name': 'Bleeding Risk'},\n",
       "     {'name': 'QTC Prolongation'},\n",
       "     {'name': 'Oncopreventive and Oncolytic Properties of SSRIs'},\n",
       "     {'name': 'Extrapyramidal Reactions Risk'},\n",
       "     {'name': 'SSRIs for Social Anxiety Disorder'},\n",
       "     {'name': 'SSRI Safety Reviews'},\n",
       "     {'name': 'Withdrawal Symptoms'},\n",
       "     {'name': 'Repeated SSRIs Exposures Effects on Dopamine Receptors'},\n",
       "     {'name': 'Hyperprolactinemia-related Symptoms'},\n",
       "     {'name': 'SRRIs and Ocular Safety'},\n",
       "     {'name': 'Risk for Orofacial Pain Disorders'},\n",
       "     {'name': 'Risk of Hallucinations'}]}]},\n",
       " 'other': {'name': 'Other',\n",
       "  'children': [{'name': 'Ecotoxicology',\n",
       "    'children': [{'name': 'Aquatic Ecotoxicology'},\n",
       "     {'name': 'Environmental Degradation of Antidepressants'}]},\n",
       "   {'name': 'Alternative Treatments',\n",
       "    'children': [{'name': 'Antidepressant-like Effects of Herbal Extracts in Animal Models'},\n",
       "     {'name': \"St. John's Wort for Depression\"}]},\n",
       "   {'name': 'Other',\n",
       "    'children': [{'name': 'SSRI Utilization Patterns'},\n",
       "     {'name': 'Pharmacoeconomics of SSRIs for Depression'},\n",
       "     {'name': 'Menopausal Vasomotor Symptoms (Hot flashes)'},\n",
       "     {'name': 'Canine Behavioral Disorders'},\n",
       "     {'name': 'Generic SSRIs'},\n",
       "     {'name': 'Critical Psychiatry'}]}]}}"
      ]
     },
     "execution_count": 96,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "class ClusterHierarchyTransformerD3JS:\n",
    "    def __init__(self, tree_data, cluster_labels_dict):\n",
    "        \"\"\"\n",
    "        Initialize the ClusterHierarchyTransformerD3JS with tree data and a cluster label mapping.\n",
    "\n",
    "        :param tree_data: The initial tree structure (dictionary).\n",
    "        :param cluster_labels_dict: Dictionary mapping of numbers to labels.\n",
    "        \"\"\"\n",
    "        self.tree_data = tree_data\n",
    "        self.cluster_labels_dict = {\n",
    "            int(k): v for k, v in cluster_labels_dict.items()\n",
    "        }  # Ensure keys are integers\n",
    "\n",
    "    def replace_numbers_with_labels(self, node):\n",
    "        \"\"\"Recursively replace numbers with labels based on the mapping.\"\"\"\n",
    "        if isinstance(node, list):\n",
    "            # Replace each number in the list with its label if it exists in the mapping\n",
    "            return [self.cluster_labels_dict[int(item)] for item in node]\n",
    "        elif isinstance(node, dict):\n",
    "            # Recursively replace keys and values in the dictionary\n",
    "            return {\n",
    "                key: self.replace_numbers_with_labels(value)\n",
    "                for key, value in node.items()\n",
    "            }\n",
    "        else:\n",
    "            # Handle individual items\n",
    "            try:\n",
    "                return self.cluster_labels_dict[int(node)]\n",
    "            except (ValueError, KeyError):\n",
    "                return node\n",
    "\n",
    "    def transform_structure(self, name, data):\n",
    "        \"\"\"Transform the structure into a detailed format with all leaves.\"\"\"\n",
    "        if isinstance(data, dict):\n",
    "            children = [\n",
    "                self.transform_structure(key, value) for key, value in data.items()\n",
    "            ]\n",
    "            return {\"name\": name, \"children\": children}\n",
    "        elif isinstance(data, list):\n",
    "            return {\"name\": name, \"children\": [{\"name\": item} for item in data]}\n",
    "        else:\n",
    "            return {\"name\": name}\n",
    "\n",
    "    def transform_overview(self, name, data):\n",
    "        \"\"\"Transform the structure for overview, skipping leaf nodes.\"\"\"\n",
    "        if isinstance(data, dict):\n",
    "            children = [\n",
    "                self.transform_overview(key, value)\n",
    "                for key, value in data.items()\n",
    "                if isinstance(value, (dict, list))\n",
    "            ]\n",
    "            return {\"name\": name, \"children\": children}\n",
    "        elif isinstance(data, list):\n",
    "            return {\"name\": name}\n",
    "        else:\n",
    "            return {\"name\": name}\n",
    "\n",
    "    def create_transformed_structure(self):\n",
    "        \"\"\"Generate the final transformed structure with overview and detailed sections.\"\"\"\n",
    "        self.tree_with_labels = self.replace_numbers_with_labels(self.tree_data)\n",
    "        self.desired_structure = {\n",
    "            \"overview\": self.transform_overview(\"Topic Overview\", self.tree_with_labels)\n",
    "        }\n",
    "\n",
    "        # Add individual topics with full details\n",
    "        for topic, content in self.tree_with_labels.items():\n",
    "            self.desired_structure[topic.lower()] = self.transform_structure(\n",
    "                topic, content\n",
    "            )\n",
    "\n",
    "        return self.desired_structure\n",
    "\n",
    "    def save_to_json(self, file_path):\n",
    "        \"\"\"Save the transformed structure to a JSON file.\"\"\"\n",
    "        with open(file_path, \"w\") as f:\n",
    "            json.dump(self.desired_structure, f, indent=2)\n",
    "        print(f\"Structure saved to {file_path}\")\n",
    "\n",
    "\n",
    "# Initialize the transformer\n",
    "transformer = ClusterHierarchyTransformerD3JS(\n",
    "    filtered_cluster_tree, filtered_cluster_labels\n",
    ")\n",
    "\n",
    "d3js_structure = transformer.create_transformed_structure()\n",
    "\n",
    "# Save to JSON\n",
    "transformer.save_to_json(\n",
    "    \"../output/cluster-qualifications/cluster-label-tree/D3JS_cluster_hierarchy_structure.json\"\n",
    ")\n",
    "d3js_structure"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{0: 'Serotonin Receptor Modulation in SSRI Treatment',\n",
       " 1: 'Aquatic Ecotoxicology',\n",
       " 2: 'Risks of Prenatal Exposure',\n",
       " 3: 'Quantification of SSRIs in Biological Samples',\n",
       " 4: 'SSRIs for Obsessive-Compulsive Disorder (OCD)',\n",
       " 5: 'SSRIs and the Cytochrome P450 System',\n",
       " 6: 'Impact of SSRIs on Neurogenesis',\n",
       " 7: 'The Chronic Unpredictable Mild Stress Model of Depression',\n",
       " 8: 'Fluvoxamine for Depression',\n",
       " 9: 'Pediatric Depression',\n",
       " 10: 'SSRIs Effect on Neural Processing of Emotional Cues',\n",
       " 11: 'Paroxetine Binding',\n",
       " 12: 'Risk of Perinatal Exposure (Rodents)',\n",
       " 13: 'SSRIs in Forced Swimming Test',\n",
       " 14: 'SSRIs for PTSD',\n",
       " 15: 'Sexual Dysfunction',\n",
       " 16: 'Serotonin Syndrome',\n",
       " 17: 'Sequenced Depression Treatment',\n",
       " 18: 'Serotonin Transporter Gene and Antidepressant Response',\n",
       " 19: 'Post-Stroke SSRI Use',\n",
       " 20: 'Bleeding Risk',\n",
       " 21: 'SSRI Utilization Patterns',\n",
       " 22: 'SSRIs for Bipolar Depression',\n",
       " 23: 'SSRIs in Dementias',\n",
       " 24: 'Escitalopram for Depression',\n",
       " 25: 'SSRIs for Pain',\n",
       " 26: 'SSRIs Effect on Fear',\n",
       " 27: 'Suicice Risk',\n",
       " 28: 'Structural Basis of Serotonin Transporter Inhibition by SSRIs',\n",
       " 29: 'SSRIs for Weight Management',\n",
       " 30: 'Pharmacoeconomics of SSRIs for Depression',\n",
       " 31: 'SSRIs for Panic Disorder',\n",
       " 32: 'Paroxetine',\n",
       " 33: 'Antidepressant-like Effects of Herbal Extracts in Animal Models',\n",
       " 34: ' Depression in Patients with Cardiovascular Disease',\n",
       " 35: 'SSRIs for (Psycho)dermatological Diseases',\n",
       " 36: 'SSRIs and Inflammation',\n",
       " 37: 'SSRIs for Generalized Anxiety Disorder (GAD)',\n",
       " 38: 'Fracture Risk',\n",
       " 39: 'Fluoxetine',\n",
       " 40: 'SSRIs Effect on Sleep',\n",
       " 41: 'Fluvoxamine for Covid 19',\n",
       " 42: 'Pharmacological Treatment Strategies of Depression',\n",
       " 43: 'QTC Prolongation',\n",
       " 44: 'Oncopreventive and Oncolytic Properties of SSRIs',\n",
       " 45: 'Premature Ejaculation',\n",
       " 46: 'Extrapyramidal Reactions Risk',\n",
       " 47: 'SSRIs for Depression in Diabetes Patients',\n",
       " 48: 'SSRIs for Premenstrual Dysphoric Disorder (PMDD)',\n",
       " 49: 'SSRIs for Depression with Cognitive Impairment',\n",
       " 50: 'SSRIs for Eating Disorders',\n",
       " 51: 'SSRIs for Alcohol Dependence',\n",
       " 52: 'SSRIs for Irritable Bowel Syndrome',\n",
       " 53: 'Menopausal Vasomotor Symptoms (Hot flashes)',\n",
       " 54: 'SSRIs for Borderline Personality Disorder',\n",
       " 55: 'SSRIs Effects on Neuroendocrine System',\n",
       " 56: '(Sertraline) Drug Delivery',\n",
       " 57: 'SSRI Synthesis',\n",
       " 58: 'SSRIs for Autism Spectrum Disorders',\n",
       " 59: 'SSRIs for Depression in in Epileptic Patients',\n",
       " 60: 'SSRIs for Substance Abuse (Cocaine)',\n",
       " 61: 'SSRIs for Depression in Parkinsons Patients',\n",
       " 62: 'SSRIs (Fluvoxamine) for Schizophrenia',\n",
       " 63: 'SSRIs for Social Anxiety Disorder',\n",
       " 64: 'SSRIs Effects on Ion Channels',\n",
       " 65: 'Harmful Drug Interactions',\n",
       " 66: 'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity',\n",
       " 67: 'Hyponatremia Risk',\n",
       " 68: 'Sertraline for Depression',\n",
       " 69: 'SSRIs Effect on Pulmonary Hypertension',\n",
       " 70: 'SSRIs for Body Dysmorphic Disorder (BDD)',\n",
       " 71: 'Forensic Drug Concentration',\n",
       " 72: 'SSRIs for Pediatric Anxiety',\n",
       " 73: 'SSRIs Effects on Antimicrobials and Gut Microbiome',\n",
       " 74: 'Geriatric Depression',\n",
       " 75: 'SSRI Safety Reviews',\n",
       " 76: 'Citalopram for Depression',\n",
       " 77: 'Agomelatin for Depression',\n",
       " 78: 'Withdrawal Symptoms',\n",
       " 79: 'Astrocyte Receptors as a Target for SSRIs',\n",
       " 80: 'Genotype Mediated Response to SSRIs',\n",
       " 81: 'Environmental Degradation of Antidepressants',\n",
       " 82: 'Hepatotoxic Risk',\n",
       " 83: 'SSRIs and Augmentation for Treatment Resistant Depression',\n",
       " 84: 'Depression Treatment in Hepatitis Patients',\n",
       " 85: 'SSRIs for Depression after Traumatic Brain Injury',\n",
       " 86: 'Repeated SSRIs Exposures Effects on Dopamine Receptors',\n",
       " 87: 'Hyperprolactinemia-related Symptoms',\n",
       " 88: 'SSRI Use',\n",
       " 89: 'SSRIs for Fibromyalgia',\n",
       " 90: 'Sex differences in SSRI Response',\n",
       " 91: 'SSRIs Effect on Male Fertility',\n",
       " 92: 'SRRIs and Ocular Safety',\n",
       " 93: 'SSRIs for Depression in Cancer',\n",
       " 94: 'Gatways to Clinical Trials',\n",
       " 95: 'Transcranial Direct Current Stimulation (tDCS) for Depression',\n",
       " 96: 'Sertraline',\n",
       " 97: 'Canine Behavioral Disorders',\n",
       " 98: 'SSRIs in Model Organisms ( C. Elegans and Drosophilia)',\n",
       " 99: 'Risk for Orofacial Pain Disorders',\n",
       " 100: 'SSRIs for Enuresis',\n",
       " 101: 'SSRIs for Migraine',\n",
       " 102: 'SSRIs for Postpartum Depression',\n",
       " 103: \"St. John's Wort for Depression\",\n",
       " 104: 'SSRIs for Behavioral Addictions',\n",
       " 105: 'SSRIs for Depression in Kidney Disease Patients',\n",
       " 106: 'Predicting SSRI Response in Depression via miRNA and BDNF',\n",
       " 107: 'SSRIs Effect on Reinforcement Learning in Rodents',\n",
       " 108: 'Generic SSRIs',\n",
       " 109: 'SSRIs for Dysthymia',\n",
       " 110: 'Vilazodone for Depression',\n",
       " 111: 'SSRIs for Trichotillomania',\n",
       " 112: 'Selective serotonin reuptake inhibitors',\n",
       " 113: 'SSRIs Long-term Efficacy and Recurrent Depression',\n",
       " 114: 'SSRIs for the Mangement of Multiple Sclerosis',\n",
       " 115: 'Neurochemical and Electrophysiological Correlates of SSRIs',\n",
       " 116: 'Movement Disorders Associated with Fluvoxamine',\n",
       " 117: 'Folate for Depression',\n",
       " 118: 'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients',\n",
       " 119: 'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients',\n",
       " 120: 'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases',\n",
       " 121: 'SSRIs for Congenital Myasthenic Syndrome (SCCMS)',\n",
       " 122: 'SSRIs for Depression in HIV-positive Patients',\n",
       " 123: 'SSRIs in the Treatment of Huntington Disease',\n",
       " 124: 'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression',\n",
       " 125: 'SSRIs for Smoking Cessation',\n",
       " 126: 'SSRIs for Syncope',\n",
       " 127: 'Olfactory Bulbectomized (OB) Rat Model of Depression',\n",
       " 128: 'Critical Psychiatry',\n",
       " 129: 'Novel Compounds Synthesis and Antidepressant Potential',\n",
       " 130: 'SSRIs for Tinnitus ',\n",
       " 131: 'Tryptophan Depletion in Depression',\n",
       " 132: 'Risk of Hallucinations',\n",
       " 133: 'Exercise for Depression',\n",
       " 134: 'SSRIs for Narcolepsy',\n",
       " 135: \"SSRIs for Tourette's Syndrome\",\n",
       " 136: 'Adulterants of SSRIs in Weight Loss Supplements',\n",
       " 137: 'Risk of Microscopic Colitis',\n",
       " 138: 'Psilocybin for Depression',\n",
       " 139: 'SSRIs for Psychotic Depression (STOP-PD Study)',\n",
       " 140: 'SSRIs for OCD-like behaviors',\n",
       " 141: 'SSRI Pharmacokinetics After Bariatric Surgery',\n",
       " 142: 'Risk of Priapism',\n",
       " 143: 'SSRIs for Depersonalization Disorder',\n",
       " 144: 'Risk of Reversible Cerebral Vasoconstriction Syndrome (RCVS)',\n",
       " 145: 'Pharmacokinetics and Brain Penetration Studies',\n",
       " 146: 'SSRIs Cellular Distribution',\n",
       " 147: 'Gateways to Clinical Trials',\n",
       " 148: 'Citalopram Effects in Developing Mouse Brain',\n",
       " 149: 'SSRIs for Olfactory reference syndrome (ORS)'}"
      ]
     },
     "execution_count": 89,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filtered_cluster_labels"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyError",
     "evalue": "'0'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[90], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m \u001b[43mfiltered_cluster_labels\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m0\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\n\u001b[1;32m      3\u001b[0m filtered_cluster_labels \u001b[38;5;241m=\u001b[39m {\u001b[38;5;28mint\u001b[39m(k): v \u001b[38;5;28;01mfor\u001b[39;00m k, v \u001b[38;5;129;01min\u001b[39;00m filtered_cluster_labels\u001b[38;5;241m.\u001b[39mitems()}\n",
      "\u001b[0;31mKeyError\u001b[0m: '0'"
     ]
    }
   ],
   "source": [
    "filtered_cluster_labels[\"0\"]\n",
    "\n",
    "filtered_cluster_labels = {int(k): v for k, v in filtered_cluster_labels.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "filtered_cluster_labels = {int(k): v for k, v in filtered_cluster_labels.items()}\n",
    "\n",
    "\n",
    "def replace_numbers_with_labels(node):\n",
    "    \"\"\"Recursively replace numbers with labels based on the mapping.\"\"\"\n",
    "    if isinstance(node, list):\n",
    "        # Replace each number in the list with its label if it exists in the mapping\n",
    "        return [filtered_cluster_labels[int(item)] for item in node]\n",
    "    elif isinstance(node, dict):\n",
    "        # Recursively replace keys and values in the dictionary\n",
    "        return {key: replace_numbers_with_labels(value) for key, value in node.items()}\n",
    "    else:\n",
    "        # Handle individual items\n",
    "        return node"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [],
   "source": [
    "twl = replace_numbers_with_labels(filtered_cluster_tree)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Pharmacology': {'Pharmacodynamics': {'Mechanism of action': ['Serotonin Receptor Modulation in SSRI Treatment',\n",
       "    'Impact of SSRIs on Neurogenesis',\n",
       "    'SSRIs Effect on Neural Processing of Emotional Cues',\n",
       "    'Paroxetine Binding',\n",
       "    'SSRIs Effect on Fear',\n",
       "    'Structural Basis of Serotonin Transporter Inhibition by SSRIs',\n",
       "    'SSRIs and Inflammation',\n",
       "    'SSRIs Effects on Neuroendocrine System',\n",
       "    'SSRIs for Substance Abuse (Cocaine)',\n",
       "    'SSRIs Effects on Ion Channels',\n",
       "    'SSRIs Effects on Antimicrobials and Gut Microbiome',\n",
       "    'Astrocyte Receptors as a Target for SSRIs',\n",
       "    'Repeated SSRIs Exposures Effects on Dopamine Receptors',\n",
       "    'SSRIs in Model Organisms ( C. Elegans and Drosophilia)',\n",
       "    'Predicting SSRI Response in Depression via miRNA and BDNF',\n",
       "    'SSRIs Effect on Reinforcement Learning in Rodents',\n",
       "    'Neurochemical and Electrophysiological Correlates of SSRIs',\n",
       "    'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients',\n",
       "    'Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases',\n",
       "    'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression',\n",
       "    'Tryptophan Depletion in Depression'],\n",
       "   'Animal Models of Disorders': ['The Chronic Unpredictable Mild Stress Model of Depression',\n",
       "    'SSRIs in Forced Swimming Test',\n",
       "    'Olfactory Bulbectomized (OB) Rat Model of Depression'],\n",
       "   'Other': ['SSRIs Effect on Pulmonary Hypertension',\n",
       "    'SRRIs and Ocular Safety']},\n",
       "  'Pharmacokinetics': ['SSRIs and the Cytochrome P450 System',\n",
       "   '(Sertraline) Drug Delivery'],\n",
       "  'Pharmacogenetics': ['Serotonin Transporter Gene and Antidepressant Response',\n",
       "   'Genotype Mediated Response to SSRIs'],\n",
       "  'Analytical Methods': ['Quantification of SSRIs in Biological Samples',\n",
       "   'Novel Compounds Synthesis and Antidepressant Potential'],\n",
       "  'Other': ['Risks of Prenatal Exposure',\n",
       "   'SSRI Synthesis',\n",
       "   'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity',\n",
       "   'SSRIs Effect on Male Fertility']},\n",
       " 'Indications': {'Disorders': {'Depressive Disorders': ['The Chronic Unpredictable Mild Stress Model of Depression',\n",
       "    'Fluvoxamine for Depression',\n",
       "    'Pediatric Depression',\n",
       "    'SSRIs in Forced Swimming Test',\n",
       "    'Sequenced Depression Treatment',\n",
       "    'Serotonin Transporter Gene and Antidepressant Response',\n",
       "    'Post-Stroke SSRI Use',\n",
       "    'SSRIs for Bipolar Depression',\n",
       "    'Escitalopram for Depression',\n",
       "    'Pharmacoeconomics of SSRIs for Depression',\n",
       "    ' Depression in Patients with Cardiovascular Disease',\n",
       "    'Pharmacological Treatment Strategies of Depression',\n",
       "    'SSRIs for Depression in Diabetes Patients',\n",
       "    'SSRIs for Depression with Cognitive Impairment',\n",
       "    'SSRIs for Depression in in Epileptic Patients',\n",
       "    'SSRIs for Depression in Parkinsons Patients',\n",
       "    'Geriatric Depression',\n",
       "    'Agomelatin for Depression',\n",
       "    'SSRIs and Augmentation for Treatment Resistant Depression',\n",
       "    'Depression Treatment in Hepatitis Patients',\n",
       "    'SSRIs for Depression after Traumatic Brain Injury',\n",
       "    'Sex differences in SSRI Response',\n",
       "    'SRRIs and Ocular Safety',\n",
       "    'Transcranial Direct Current Stimulation (tDCS) for Depression',\n",
       "    'SSRIs for Depression in Cancer',\n",
       "    'SSRIs for Dysthymia',\n",
       "    'SSRIs for Postpartum Depression',\n",
       "    \"St. John's Wort for Depression\",\n",
       "    'SSRIs for Depression in Kidney Disease Patients',\n",
       "    'SSRIs for Depression in Kidney Disease Patients',\n",
       "    'Predicting SSRI Response in Depression via miRNA and BDNF',\n",
       "    'Vilazodone for Depression',\n",
       "    'SSRIs for the Mangement of Multiple Sclerosis',\n",
       "    'Folate for Depression',\n",
       "    'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients',\n",
       "    'SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients',\n",
       "    'SSRIs for Depression in HIV-positive Patients',\n",
       "    'Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression',\n",
       "    'Olfactory Bulbectomized (OB) Rat Model of Depression',\n",
       "    'Tryptophan Depletion in Depression'],\n",
       "   'Anxiety': ['SSRIs Effect on Fear',\n",
       "    'SSRIs for Panic Disorder',\n",
       "    'SSRIs for Generalized Anxiety Disorder (GAD)',\n",
       "    'SSRIs for Social Anxiety Disorder',\n",
       "    'SSRIs for Pediatric Anxiety'],\n",
       "   'Weight and Eating Disorders': ['SSRIs for Weight Management',\n",
       "    'SSRIs for Eating Disorders'],\n",
       "   'Substance Abuse/Addictions': ['SSRIs for Alcohol Dependence',\n",
       "    'SSRIs for Substance Abuse (Cocaine)',\n",
       "    'SSRIs for Behavioral Addictions',\n",
       "    'SSRIs for Smoking Cessation'],\n",
       "   'Other': ['SSRIs for Obsessive-Compulsive Disorder (OCD)',\n",
       "    'SSRIs for PTSD',\n",
       "    'SSRIs in Dementias',\n",
       "    'SSRIs for Pain',\n",
       "    'SSRIs for (Psycho)dermatological Diseases',\n",
       "    'SSRIs Effect on Sleep',\n",
       "    'Fluvoxamine for Covid 19',\n",
       "    'Premature Ejaculation',\n",
       "    'SSRIs for Premenstrual Dysphoric Disorder (PMDD)',\n",
       "    'SSRIs for Irritable Bowel Syndrome',\n",
       "    'Menopausal Vasomotor Symptoms (Hot flashes)',\n",
       "    'SSRIs for Borderline Personality Disorder',\n",
       "    'SSRIs for Autism Spectrum Disorders',\n",
       "    'SSRIs (Fluvoxamine) for Schizophrenia',\n",
       "    'SSRIs Effect on Pulmonary Hypertension',\n",
       "    'SSRIs for Body Dysmorphic Disorder (BDD)',\n",
       "    'SSRIs for Fibromyalgia',\n",
       "    'Risk for Orofacial Pain Disorders',\n",
       "    'SSRIs for Enuresis',\n",
       "    'SSRIs for Migraine',\n",
       "    'SSRIs for Trichotillomania',\n",
       "    'SSRIs for Congenital Myasthenic Syndrome (SCCMS)',\n",
       "    'SSRIs in the Treatment of Huntington Disease',\n",
       "    'SSRIs for Tinnitus ',\n",
       "    'SSRIs for Syncope']}},\n",
       " 'Safety': {'Special Populations': {'Pediatrics': ['Pediatric Depression',\n",
       "    'SSRIs for Pediatric Anxiety'],\n",
       "   'Geriatrics': ['SSRIs in Dementias',\n",
       "    'Fracture Risk',\n",
       "    'SSRIs for Depression with Cognitive Impairment',\n",
       "    'SSRIs for Depression in Parkinsons Patients',\n",
       "    'Harmful Drug Interactions',\n",
       "    'Hyponatremia Risk',\n",
       "    'Geriatric Depression'],\n",
       "   'Other': ['Post-Stroke SSRI Use',\n",
       "    ' Depression in Patients with Cardiovascular Disease',\n",
       "    'SSRIs for Depression in Diabetes Patients',\n",
       "    'SSRIs for Depression in in Epileptic Patients',\n",
       "    'Depression Treatment in Hepatitis Patients',\n",
       "    'SSRIs for Depression after Traumatic Brain Injury',\n",
       "    'SSRIs for Depression in Cancer',\n",
       "    'SSRIs for Depression in Kidney Disease Patients',\n",
       "    'SSRIs for the Mangement of Multiple Sclerosis',\n",
       "    'SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients',\n",
       "    'SSRIs for Depression in HIV-positive Patients']},\n",
       "  'Perinatal Exposure': ['Risks of Prenatal Exposure',\n",
       "   'Risk of Perinatal Exposure (Rodents)',\n",
       "   'SSRIs for Postpartum Depression'],\n",
       "  'Suicide': ['The Chronic Unpredictable Mild Stress Model of Depression',\n",
       "   'Suicice Risk'],\n",
       "  'Sexual Dysfunction': ['Sexual Dysfunction',\n",
       "   'SSRIs Effect on Male Fertility'],\n",
       "  'Toxicity': ['Serotonin Syndrome',\n",
       "   'Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity',\n",
       "   'Forensic Drug Concentration',\n",
       "   'Hepatotoxic Risk'],\n",
       "  'Other': ['Bleeding Risk',\n",
       "   'QTC Prolongation',\n",
       "   'Oncopreventive and Oncolytic Properties of SSRIs',\n",
       "   'Extrapyramidal Reactions Risk',\n",
       "   'SSRIs for Social Anxiety Disorder',\n",
       "   'SSRI Safety Reviews',\n",
       "   'Withdrawal Symptoms',\n",
       "   'Repeated SSRIs Exposures Effects on Dopamine Receptors',\n",
       "   'Hyperprolactinemia-related Symptoms',\n",
       "   'SRRIs and Ocular Safety',\n",
       "   'Risk for Orofacial Pain Disorders',\n",
       "   'Risk of Hallucinations']},\n",
       " 'Other': {'Ecotoxicology': ['Aquatic Ecotoxicology',\n",
       "   'Environmental Degradation of Antidepressants'],\n",
       "  'Alternative Treatments': ['Antidepressant-like Effects of Herbal Extracts in Animal Models',\n",
       "   \"St. John's Wort for Depression\"],\n",
       "  'Other': ['SSRI Utilization Patterns',\n",
       "   'Pharmacoeconomics of SSRIs for Depression',\n",
       "   'Menopausal Vasomotor Symptoms (Hot flashes)',\n",
       "   'Canine Behavioral Disorders',\n",
       "   'Generic SSRIs',\n",
       "   'Critical Psychiatry']}}"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "twl"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0\n",
      "6\n",
      "10\n",
      "11\n",
      "26\n",
      "28\n",
      "36\n",
      "55\n",
      "60\n",
      "64\n",
      "73\n",
      "79\n",
      "86\n",
      "98\n",
      "106\n",
      "107\n",
      "115\n",
      "119\n",
      "120\n",
      "124\n",
      "131\n",
      "7\n",
      "13\n",
      "127\n",
      "69\n",
      "92\n",
      "5\n",
      "56\n",
      "18\n",
      "80\n",
      "3\n",
      "129\n",
      "2\n",
      "57\n",
      "66\n",
      "91\n",
      "7\n",
      "8\n",
      "9\n",
      "13\n",
      "17\n",
      "18\n",
      "19\n",
      "22\n",
      "24\n",
      "30\n",
      "34\n",
      "42\n",
      "47\n",
      "49\n",
      "59\n",
      "61\n",
      "74\n",
      "77\n",
      "83\n",
      "84\n",
      "85\n",
      "90\n",
      "92\n",
      "95\n",
      "93\n",
      "109\n",
      "102\n",
      "103\n",
      "105\n",
      "105\n",
      "106\n",
      "110\n",
      "114\n",
      "117\n",
      "118\n",
      "119\n",
      "122\n",
      "124\n",
      "127\n",
      "131\n",
      "26\n",
      "31\n",
      "37\n",
      "63\n",
      "72\n",
      "29\n",
      "50\n",
      "51\n",
      "60\n",
      "104\n",
      "125\n",
      "4\n",
      "14\n",
      "23\n",
      "25\n",
      "35\n",
      "40\n",
      "41\n",
      "45\n",
      "48\n",
      "52\n",
      "53\n",
      "54\n",
      "58\n",
      "62\n",
      "69\n",
      "70\n",
      "89\n",
      "99\n",
      "100\n",
      "101\n",
      "111\n",
      "121\n",
      "123\n",
      "130\n",
      "126\n",
      "9\n",
      "72\n",
      "23\n",
      "38\n",
      "49\n",
      "61\n",
      "65\n",
      "67\n",
      "74\n",
      "19\n",
      "34\n",
      "47\n",
      "59\n",
      "84\n",
      "85\n",
      "93\n",
      "105\n",
      "114\n",
      "118\n",
      "122\n",
      "2\n",
      "12\n",
      "102\n",
      "7\n",
      "27\n",
      "15\n",
      "91\n",
      "16\n",
      "66\n",
      "71\n",
      "82\n",
      "20\n",
      "43\n",
      "44\n",
      "46\n",
      "63\n",
      "75\n",
      "78\n",
      "86\n",
      "87\n",
      "92\n",
      "99\n",
      "132\n",
      "1\n",
      "81\n",
      "33\n",
      "103\n",
      "21\n",
      "30\n",
      "53\n",
      "97\n",
      "108\n",
      "128\n"
     ]
    }
   ],
   "source": [
    "twl = replace_numbers_with_labels(filtered_cluster_tree)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "condavenv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
